Ministry of Health: AstraZeneca Vaccine for Government Program Vaccination Page all

JAKARTA, KOMPAS.com – Spokesman Covid-19 Vaccination Ministry of Health (Kemenkes) Siti Nadia Tarmizi said the vaccine made by AstraZeneca would be used for the government’s national program.

Currently, the government’s vaccination program uses a vaccine from Sinovac, which was developed by a Chinese pharmaceutical manufacturer.

“Yes, for government program vaccinations. As stated by the Minister of Health, the government program vaccination uses Sinovac, Pfizer, AstraZeneca, Novavax, and one that we will get from the Covax mechanism. facility, “said Nadia when confirmed Kompas.com, Wednesday (10/3/2021).

Also read: Get to know AstraZeneca’s Covid-19 Vaccine that Can Get BPOM Emergency Use Permit

Nadia said the government guarantees the safety of the AstraZeneca vaccine.

If there is a Post-Immunization Follow-Up Event (KIPI), the government has prepared a handling mechanism.

“Then when the vaccine will be given there are also criteria for screening, “he added.

The Food and Drug Supervisory Agency (BPOM) has announced the issuance of an emergency use permit or emergency use authorization (EUA) for the AstraZeneca vaccine.

Head of BPOM Penny Lukito said the application for the permit for the emergency use of the Covid-19 vaccine was carried out through two channels, namely multilaterally and registered directly by AstraZeneca Indonesia.

According to Penny, before granting an emergency use permit, BPOM had conducted an evaluation with the National Committee for Drug Evaluation and other parties.

Covid-19 AstraZeneca vaccine it has an efficacy of 62.1 percent

Also read: BPOM Issues AstraZeneca Covid-19 Vaccine Emergency Use Permit

Previously, as many as 1.1 million doses of vaccine obtained through a multilateral cooperation scheme arrived at Soekarno-Hatta International Airport, Tangerang, Monday (8/3/2021) at around 17.45 WIB.

The first shipment of vaccines via a multilateral scheme or the sixth stage of the Indonesian Government’s vaccine delivery includes the Covid-19 vaccine from the pharmaceutical company AstraZeneca.

The vaccine was obtained through a multilateral cooperation scheme between the Government of Indonesia and the Global Alliance for Vaccines and Immunization (GAVI), the World Health Organization (WHO), UNICEF, Coalition for Epidemic Preparedness Innovations (CEPI), and various other international parties through the Covid-19 Vaccines initiative. Global Access (COVAX) Facility.

Also read: BPOM: The efficacy of AstraZeneca’s Covid-19 Vaccine is 62.1 percent

This global initiative aims to strive for equal access to Covid-19 vaccines for all countries.

The arrival of 1,113,600 AstraZeneca vaccines this time is the initial part of the first batch of vaccines imported through a multilateral scheme.

Indonesia will get 11,704,800 ready-to-use vaccines and efforts are made to be able to continue in the next waves.

As for the AstraZeneca vaccine it has gone inside emergency use listing (EUL) or WHO emergency use list since February 15, 2021.

– .